三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
百拓维与诺雷得在前列腺癌男性患者中去势效果相若
百拓维与诺雷得在前列腺癌男性患者中去势效果相若
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:44KB
图片尺寸:1084*702
同报告图片
/
4
5qC55o2u5Zu+54mH5Lit55qE5p+x54q25Zu+77yM5Y+v5Lul5o+Q5Y+W5Lul5LiL5pWw5o2u77yaCgp8IOiNr+eJqSAgIHwg5q+U5L6LICAgfAp8LS0tLS0tLS18LS0tLS0tLS18Cnwg55m+5ouT57u0IHwgOTkuMyUgIHwKfCDor7rpm7flvpcgfCAxMDAuMCUgfAoK6LWE5paZ5p2l5rqQ77ya5Zu95a625Yy75L+d5bGA77yM5Lit5rOw5Zu96ZmF56CU56m26YOo
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
所属报告:
绿叶制药-公司首次覆盖报告:核心产品需求稳定多款新药将逐步兑现-241217(23页).pdf
打包全文图表
相关数据
安百拓后市场(服务+配件)收入及变化趋势
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
收藏
行业数据
2026-01-29
原图定位
查看详情
安百拓订单情况(按业务领域分布)
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
收藏
行业数据
2026-01-29
原图定位
查看详情
图表242020年至2030年中国前列腺癌发病人数(万人)
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
收藏
行业数据
2025-12-22
原图定位
查看详情
图表232020年至2030年全球前列腺癌发病人数(万人)
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
收藏
行业数据
2025-12-22
原图定位
查看详情
全球PARP抑制剂前列腺癌适应症后期临床项目
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
收藏
行业数据
2025-09-28
原图定位
查看详情
已上市PARP抑制剂治疗前列腺癌的疗效及安全性对比
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
收藏
行业数据
2025-09-28
原图定位
查看详情
国内PARP抑制剂前列腺癌竞争格局
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
收藏
竞争格局
2025-09-28
原图定位
查看详情
2021-2024年拓尔思各行业收入(单位:百
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
收藏
行业数据
2025-08-06
原图定位
查看详情
2021-2024年拓尔思各产品收入(单位:百
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
收藏
行业数据
2025-08-06
原图定位
查看详情
2025Q1安百拓后市场营收占比达67%
5qC55o2u5oKo5o+Q5L6b55qE5L+h5oGv77yM5Lul5LiL5piv5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgojIyMg5pWw5o2u6KGo5qC8Cgp8IOexu+WIqyAgICAgICB8IOeZvuWIhuavlCB8IOaVsOWAvCB8CnwtLS0tLS0tLS0tLS18LS0tLS0tLS18LS0tLS0tfAp8IEFmdGVybWFya2V0fCA2NyUgICAgfCA2NyAgIHwKfCBTZXJ2aWNlICAgIHwgNDMlICAgIHwgNDYgICB8CnwgRXF1aXBtZW50ICB8IDMzJSAgICB8IDMzICAgfAp8IFQmQSAgICAgICAgfCAyNCUgICAgfCAyMSAgIHwKCiMjIyDotYTmlpnmnaXmupAKV2luZO+8jOivmumAmuivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-07-15
原图定位
查看详情
表8、ARPROTAC在去势抵抗前列腺癌(CRPC)的临床数据对比
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
收藏
行业数据
2025-05-23
原图定位
查看详情
2021-2024年拓维信息算力业务收入
5Lul5LiL5piv5o+Q5Y+W55qE5pWw5o2u5bm255Sf5oiQ55qE6KGo5qC877yaCgp8IOW5tOS7vSAgfCDmi5Pnu7Tkv6Hmga/nrpflipvmlLblhaUgfAp8LS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfAp8IDIwMjEgIHwgNy4xMCAgICAgICAgICAgfAp8IDIwMjIgIHwgOC4wNSAgICAgICAgICAgfAp8IDIwMjMgIHwgMTcuNzYgICAgICAgICAgfAp8IDIwMjQgIHwgMjAuNzIgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yad2luZO+8jOawkeeUn+ivgeWIuOeglOeptumZog==
收藏
行业数据
2025-05-19
原图定位
查看详情
前列腺癌治疗常用药物及其作用机理
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
收藏
行业数据
2025-03-11
原图定位
查看详情
中国前列腺癌新增病例和死亡人数
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
收藏
行业数据
2025-03-11
原图定位
查看详情
全球前列腺癌用药市场销售额预测(十亿美元)
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
收藏
行业数据
2025-03-11
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
我们预计百拓维的销售收入在 2023-26E 期间将从约 4,985 万元增加至 9,975 万元,2023-26E CAGR 为26.0%。基于:1)前列腺癌为最常见的癌症之一,药物需求在提升。戈舍瑞林属国家诊疗指南近年强烈推荐的 ADT 疗法,并且是目前国内最常用的前列腺癌药物之一,2018-22 年市场份额始终稳定在 20%以上并排名行业第二,表明此类产品在医疗机构的认可度很高。百拓维的微球剂型疗效与原先的植入剂诺雷得相比,维持去势方面的效果略优,而且药物稳定性较强,安全性也较高。2)百拓维在乳腺癌治疗方面也表现出较好的疗效与安全性。研究表明很多乳腺癌病人血清中的雌二醇异常增高,该现象与乳腺癌的发生发展密切相关。戈舍瑞林能有效降低女性血清雌二醇含量,因此此类药物在乳腺癌治疗中效果较好。临床试验表明,百拓维能将很多患者的血清雌二醇维持在绝经后水平,因此被中国抗癌协会纳入《乳腺癌诊疗指南(2024年)》 I级推荐。3)除较好的疗效以外,百拓维的针头大小明显小于原研药诺雷得,而注射方式从腹部皮下注射改为臀部或者大腿肌注,因此能大幅降低注射疼痛程度,并提升患者依从性。
行业数据
原图定位
当前图表所属:
绿叶制药-公司首次覆盖报告:核心产品需求稳定多款新药将逐步兑现-241217(23页).pdf
若欣林HAM-D17总分基线变化(单位:百万人民币)
若欣林MADRS总分较基数变化
阿尔兹海默症患者脑部结构变化
公司主要业务销售收入(12月31日年结,百万人民币)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》